Related Experiment Video
Updated: Aug 11, 2026
11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.2K
Predicting Multiple Sclerosis: Challenges and Opportunities
Luke Hone1, Gavin Giovannoni1,2, Ruth Dobson1,2
1Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and Queen Mary University of London, London, United Kingdom.
Frontiers in Neurology
|February 25, 2022
Summary
Developing predictive risk scores using genetic and environmental data can help identify individuals at high risk for Multiple Sclerosis (MS) for prevention trials. These scores aid trial design but are not yet suitable for individual clinical prediction.
Area of Science:
- Neuroimmunology
- Clinical Trial Design
- Biostatistics
Background:
- Multiple Sclerosis (MS) prevention research requires large or enriched populations due to low disease incidence.
- Identifying high-risk individuals is crucial for efficient clinical trials of preventive strategies.
Purpose of the Study:
- To explore the development and application of predictive risk scores for identifying individuals at high risk of Multiple Sclerosis (MS).
- To assess the potential of risk scores in stratifying populations for MS prevention trials.
Main Methods:
- Review of concepts for developing predictive scores integrating genetic and environmental factors.
- Analysis of empirical efforts using real-world cohorts to build and validate risk scores.
- Discussion of theoretical and practical challenges in predictive score development.
Main Results:
- Predictive scores can theoretically identify individuals at higher risk for MS.
- Empirical studies show promise but face significant theoretical and practical limitations.
- Risk stratification for trials is a feasible application.
Conclusions:
- Predictive risk scores show potential for enhancing Multiple Sclerosis (MS) prevention trial design through risk stratification.
- Current scores are unlikely to be clinically useful for predicting MS in individual patients.
- Further research is needed to overcome challenges in developing robust predictive models.
